{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T22:05:38Z","timestamp":1781129138604,"version":"3.54.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2017,2,13]],"date-time":"2017-02-13T00:00:00Z","timestamp":1486944000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100007229","name":"Bijzonder Onderzoeksfonds","doi-asserted-by":"publisher","award":["BOF27327"],"award-info":[{"award-number":["BOF27327"]}],"id":[{"id":"10.13039\/501100007229","id-type":"DOI","asserted-by":"publisher"}]},{"name":"iMinds ICON FIAT (Functional Image Analysis of Tumors)"},{"name":"iMinds ICON FIAT (Functional Image Analysis of Tumors)"},{"name":"Innovative Medicines Initiative Joint Undertaking","award":["115151"],"award-info":[{"award-number":["115151"]}]},{"name":"Innovative Medicines Initiative Joint Undertaking","award":["115151"],"award-info":[{"award-number":["115151"]}]},{"name":"iMinds ICON FIAT (Functional Image Analysis of Tumors)"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Imaging Biol"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1007\/s11307-017-1051-4","type":"journal-article","created":{"date-parts":[[2017,2,13]],"date-time":"2017-02-13T13:21:33Z","timestamp":1486992093000},"page":"762-771","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Characterization of an Orthotopic Colorectal Cancer Mouse Model and Its Feasibility for Accurate Quantification in Positron Emission Tomography"],"prefix":"10.1007","volume":"19","author":[{"given":"Sara","family":"Rapic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christel","family":"Vangestel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeroen","family":"Verhaeghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Van den Wyngaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rukun","family":"Hinz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marleen","family":"Verhoye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Pauwels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Staelens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1285-9117","authenticated-orcid":false,"given":"Sigrid","family":"Stroobants","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,2,13]]},"reference":[{"key":"1051_CR1","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3322\/caac.21262","volume":"65","author":"LA Torre","year":"2015","unstructured":"Torre LA, Bray F, Siegel RL et al (2015) Global cancer statistics, 2012. CA-Cancer J Clin 65:87\u2013108","journal-title":"CA-Cancer J Clin"},{"key":"1051_CR2","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1097\/PPO.0b013e3181e07738","volume":"16","author":"PM Wilson","year":"2010","unstructured":"Wilson PM, Labonte MJ, Lenz H-J (2010) Molecular markers in the treatment of metastatic colorectal cancer. Cancer J 16:262\u2013272","journal-title":"Cancer J"},{"key":"1051_CR3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5487\/TR.2014.30.1.001","volume":"30","author":"J Jung","year":"2014","unstructured":"Jung J (2014) Human tumor xenograft models for preclinical assessment of anticancer drug development. Toxicol Res 30:1\u20135","journal-title":"Toxicol Res"},{"key":"1051_CR4","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1158\/1535-7163.MCT-06-0391","volume":"5","author":"BA Teicher","year":"2006","unstructured":"Teicher BA (2006) Tumor models for efficacy determination. Mol Cancer Ther 5:2435\u20132443","journal-title":"Mol Cancer Ther"},{"key":"1051_CR5","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/nprot.2007.25","volume":"2","author":"CL Morton","year":"2007","unstructured":"Morton CL, Houghton PJ (2007) Establishment of human tumor xenografts in immunodeficient mice. Nat Protoc 2:247\u2013250","journal-title":"Nat Protoc"},{"key":"1051_CR6","doi-asserted-by":"crossref","first-page":"793","DOI":"10.2353\/ajpath.2007.060929","volume":"170","author":"JE Talmadge","year":"2007","unstructured":"Talmadge JE, Singh RK, Fidler IJ, Raz A (2007) Murine models to evaluate novel and conventional therapeutic strategies for cancer. Am J Pathol 170:793\u2013804","journal-title":"Am J Pathol"},{"key":"1051_CR7","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1054\/bjoc.2001.1796","volume":"84","author":"JI Johnson","year":"2001","unstructured":"Johnson JI, Decker S, Zaharevitz D et al (2001) Relationships between drug activity in NCI preclinical in vitro and in vivo models and early clinical trials. Br J Cancer 84:1424\u20131431","journal-title":"Br J Cancer"},{"key":"1051_CR8","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/clpt.2008.200","volume":"85","author":"B Rubio-Viqueira","year":"2009","unstructured":"Rubio-Viqueira B, Hidalgo M (2009) Direct in vivo xenograft tumor model for predicting chemotherapeutic drug response in cancer patients. Clin Pharmacol Ther 85:217\u2013221","journal-title":"Clin Pharmacol Ther"},{"key":"1051_CR9","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1136\/gutjnl-2011-301585","volume":"62","author":"C Hackl","year":"2012","unstructured":"Hackl C, Man S, Francia G et al (2012) Metronomic oral topotecan prolongs survival and reduces liver metastasis in improved preclinical orthotopic and adjuvant therapy colon cancer models. Gut 62:259\u2013271","journal-title":"Gut"},{"key":"1051_CR10","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.ejca.2003.11.021","volume":"40","author":"MC Bibby","year":"2004","unstructured":"Bibby MC (2004) Orthotopic models of cancer for preclinical drug evaluation. Eur J Cancer 40:852\u2013857","journal-title":"Eur J Cancer"},{"key":"1051_CR11","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1023\/A:1006326203858","volume":"17","author":"RM Hoffman","year":"1999","unstructured":"Hoffman RM (1999) Orthotopic metastatic mouse models for anticancer drug discovery and evaluation: a bridge to the clinic. Investig New Drugs 17:343\u2013359","journal-title":"Investig New Drugs"},{"key":"1051_CR12","first-page":"484","volume":"10","author":"W Tseng","year":"2007","unstructured":"Tseng W, Leong X, Engleman E (2007) Orthotopic mouse model of colorectal cancer. JoVE 10:484","journal-title":"JoVE"},{"key":"1051_CR13","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.1158\/1078-0432.CCR-09-2384","volume":"16","author":"WW Tseng","year":"2010","unstructured":"Tseng WW, Winer D, Kenkel JA et al (2010) Development of an orthotopic model of invasive pancreatic cancer in an immunocompetent murine host. Clin Cancer Res 16:3684\u20133695","journal-title":"Clin Cancer Res"},{"key":"1051_CR14","first-page":"e50873","volume":"79","author":"J Pavese","year":"2013","unstructured":"Pavese J, Ogden IM, Bergan RC (2013) An orthotopic murine model of human prostate cancer metastasis. JoVE 79:e50873","journal-title":"JoVE"},{"key":"1051_CR15","doi-asserted-by":"crossref","first-page":"e0135220","DOI":"10.1371\/journal.pone.0135220","volume":"10","author":"IS Haldorsen","year":"2015","unstructured":"Haldorsen IS, Popa M, Fonnes T et al (2015) Multimodal imaging of orthotopic mouse model of endometrial carcinoma. PLoS One 10:e0135220","journal-title":"PLoS One"},{"key":"1051_CR16","first-page":"4415","volume":"30","author":"HST Cao","year":"2010","unstructured":"Cao HST, Kaushal S, Snyder CS et al (2010) Real-time imaging of tumor progression in a fluorescent orthotopic mouse model of thyroid cancer. Anticancer Res 30:4415\u20134422","journal-title":"Anticancer Res"},{"key":"1051_CR17","doi-asserted-by":"crossref","unstructured":"Yahyanejad S, Granton PV, Lieuwes NG, et al. (2015) Complementary use of bioluminescence imaging and contrast-enhanced micro-computed tomography in an orthotopic brain tumor model. Mol Imaging","DOI":"10.2310\/7290.2014.00038"},{"key":"1051_CR18","doi-asserted-by":"crossref","unstructured":"Partecke IL, Kaeding A, Sendler M, et al. (2011) In vivo imaging of pancreatic tumours and liver metastases using 7 Tesla MRI in a murine orthotopic pancreatic cancer model and a liver metastases model. BMC Cancer","DOI":"10.1186\/1471-2407-11-40"},{"key":"1051_CR19","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","volume":"45","author":"EA Eisenhauer","year":"2009","unstructured":"Eisenhauer EA, Therasse P, Bogaerts J et al (2009) New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 45:228\u2013247","journal-title":"Eur J Cancer"},{"key":"1051_CR20","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1748-717X-3-44","volume":"3","author":"DC Weber","year":"2008","unstructured":"Weber DC, Zilli T, Buchegger F et al (2008) [(18)F]Fluoroethyltyrosine- positron emission tomography-guided radiotherapy for high-grade glioma. Radiat Oncol 3:44","journal-title":"Radiat Oncol"},{"key":"1051_CR21","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1634\/theoncologist.13-S2-8","volume":"13","author":"AD Van den Abbeele","year":"2008","unstructured":"Van den Abbeele AD (2008) The lessons of GIST-PET and PET\/CT: a new paradigm for imaging. Oncologist 13:8\u201313","journal-title":"Oncologist"},{"key":"1051_CR22","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.molonc.2012.02.005","volume":"6","author":"MF Kircher","year":"2012","unstructured":"Kircher MF, Hricak H, Larson SM (2012) Molecular imaging for personalized cancer care. Mol Oncol 6:182\u2013195","journal-title":"Mol Oncol"},{"key":"1051_CR23","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1089\/cbr.2009.0658","volume":"25","author":"G Mees","year":"2010","unstructured":"Mees G, Vangestel C, Dierckx R et al (2010) Carbonic anhydrase IX expression correlates with FDG uptake by primary non-small cell lung cancer. Cancer Biother Radiopharm 25:149\u2013154","journal-title":"Cancer Biother Radiopharm"},{"key":"1051_CR24","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/bjc.1995.331","volume":"72","author":"K Maeda","year":"1995","unstructured":"Maeda K, Chung YS, Takatsuka S et al (1995) Tumour angiogenesis and tumour cell proliferation as prognostic indicators in gastric carcinoma. Br J Cancer 72:319\u2013323","journal-title":"Br J Cancer"},{"key":"1051_CR25","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1002\/cmmi.1689","volume":"11","author":"JG Mannheim","year":"2016","unstructured":"Mannheim JG, Schlichthaerle T, Kuebler L et al (2016) Comparison of small animal CT contrast agents. Contrast Media Mol Imaging 11:272\u2013284","journal-title":"Contrast Media Mol Imaging"},{"key":"1051_CR26","doi-asserted-by":"crossref","first-page":"e25692","DOI":"10.1371\/journal.pone.0025692","volume":"6","author":"H Boll","year":"2011","unstructured":"Boll H, Nittka S, Doyon F et al (2011) Micro-CT based experimental liver imaging using a nanoparticulate contrast agent: a longitudinal study in mice. PLoS One 6:e25692","journal-title":"PLoS One"},{"key":"1051_CR27","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/j.acra.2013.06.003","volume":"20","author":"L Nebuloni","year":"2013","unstructured":"Nebuloni L, Kuhn GA, Mueller R (2013) A comparative analysis of water-soluble and blood-pool contrast agents for in vivo vascular imaging with micro-CT. Acad Radiol 20:1247\u20131255","journal-title":"Acad Radiol"},{"key":"1051_CR28","doi-asserted-by":"crossref","first-page":"6957","DOI":"10.3390\/s130606957","volume":"13","author":"CA Wathen","year":"2013","unstructured":"Wathen CA, Foje N, van Avermaete T et al (2013) In vivo X-ray computed tomographic imaging of soft tissue with native, intravenous, or oral contrast. Sensors 13:6957\u20136980","journal-title":"Sensors"},{"key":"1051_CR29","first-page":"82S","volume":"45","author":"RL Wahl","year":"2004","unstructured":"Wahl RL (2004) Why nearly all PET of abdominal and pelvic cancers will be performed as PET\/CT. J Nucl Med 45:82S\u201395S","journal-title":"J Nucl Med"},{"key":"1051_CR30","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.2353\/ajpath.2007.060773","volume":"170","author":"MV C\u00e9spedes","year":"2007","unstructured":"C\u00e9spedes MV, Espina C, Garc\u00eda-Cabezas MA et al (2007) Orthotopic microinjection of human colon cancer cells in nude mice induces tumor foci in all clinically relevant metastatic sites. Am J Pathol 170:1077\u20131085","journal-title":"Am J Pathol"},{"key":"1051_CR31","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1007\/s11307-015-0926-5","volume":"18","author":"S De Bruycker","year":"2016","unstructured":"De Bruycker S, Vangestel C, Van den Wyngaert T et al (2016) Baseline [18F]FMISO \u03bcPET as a predictive biomarker for response to HIF-1\u03b1 inhibition combined with 5-FU chemotherapy in a human colorectal cancer xenograft model. Mol Imaging Biol 18:606\u2013616","journal-title":"Mol Imaging Biol"},{"key":"1051_CR32","doi-asserted-by":"crossref","first-page":"5301","DOI":"10.3748\/wjg.v22.i23.5301","volume":"22","author":"N Mukaida","year":"2016","unstructured":"Mukaida N, Sasaki S (2016) Fibroblasts, an inconspicuous but essential player in colon cancer development and progression. World J Gastroenterol 22:5301\u20135316","journal-title":"World J Gastroenterol"},{"key":"1051_CR33","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1148\/rg.255045122","volume":"25","author":"C Love","year":"2005","unstructured":"Love C, Tomas MB, Tronco GG, Palestro CJ (2005) FDG PET of infection and inflammation. Radiographics 25:1357\u20131368","journal-title":"Radiographics"},{"key":"1051_CR34","doi-asserted-by":"crossref","first-page":"206875","DOI":"10.1155\/2013\/206875","volume":"2013","author":"A Rajput","year":"2013","unstructured":"Rajput A, Agarwal E, Leiphrakpam P et al (2013) Establishment and validation of an orthotopic metastatic mouse model of colorectal cancer. ISRN Hepatol 2013:206875","journal-title":"ISRN Hepatol"}],"container-title":["Molecular Imaging and Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11307-017-1051-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11307-017-1051-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11307-017-1051-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,18]],"date-time":"2019-09-18T12:39:44Z","timestamp":1568810384000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11307-017-1051-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,13]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["1051"],"URL":"https:\/\/doi.org\/10.1007\/s11307-017-1051-4","relation":{},"ISSN":["1536-1632","1860-2002"],"issn-type":[{"value":"1536-1632","type":"print"},{"value":"1860-2002","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,13]]}}}